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Abstract 
Arginine is widely used in refolding, purification, analysis and formulation of proteins, 
primarily because of its ability to suppress protein–protein and protein–surface 
interactions. Such a property of arginine is at least partially attributable to its affinity for 
the aromatic groups present in proteins. Herein, we have extended its study further to 
characterize arginine in terms of its affinity for heteroaromatic compounds, using 
nucleobases as a model compound. Arginine increased the solubility of all nucleobases 
tested when these nucleobases were electrically neutral, indicating that arginine interacts 
favorably with these heteroaromatics. The observed effects of arginine on the solubility 
of nucleobases suggest that arginine should stabilize the melted state of nucleic acids, in 
which the nucleobases are more solvent-exposed. In an acidic solution, to our surprise, 
arginine decreased the solubility of positively charged nucleobases. 
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Introduction 
Arginine is widely used in research and development of proteins, such as refolding, 
chromatography, analysis, and formulation of proteins. Such applications are based on 
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the ability of arginine to suppress protein–protein and protein–surface interactions [1–8]. 
Various approaches to address the mechanism of arginine effects have been performed, 
namely a study of the preferential interaction of arginine with proteins [9] and 
comparison of chemical structures of arginine derivatives in relation to their effects on 
protein aggregation [10–12]. The transfer free energy concept, established by a 
pioneering work of Nozaki and Tanford in the 1960s and 1970s [13–16], revealed that 
arginine interacts favorably with aromatic groups that are present in proteins, i.e. 
phenylalanine, tyrosine and tryptophan, through the π–electron of these groups [6]. 
Recently, we observed that arginine increases the solubility of low molecular weight 
aromatic compounds [17,18]. The results, which confirmed the affinity of arginine for 
aromatic groups, further suggested that arginine is applicable to the progress of drug 
development because the poor solubility of some drugs, namely biopharmaceutical 
classification system (BCS) type II and IV drugs, exhibit low bioavailability. However, 
those earlier studies have been limited to aromatic hydrocarbons, while many drug 
substances are also composed of heteroaromatics. Consequently, we studied the ability of 
arginine to modulate the solubility of heteroaromatic compounds using nucleobases as a 
model compound. The observed effects of arginine present important implications, not 
only in the ability to change the solubility of heteroaromatic drug substances, but also in 
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the interaction of guanidinium group of arginine with heteroaromatic ring-containing 
compounds, as discussed in this paper. 
 
Materials and methods 
Chemicals 
 For this study, adenine, guanine, thymine, cytosine, uracil, arginine hydrochloride (HCl), 
lysine HCl, glutamic acid, aspartic acid, glycine, NaCl, guanidine HCl and trisodium 
citrate dihydrate were used (Wako Pure Chemical Industries Ltd., Osaka, Japan), along 
with sodium dihydrogenphosphate dehydrate (Nacalai Tesque Inc., Kyoto, Japan). All 
compounds were of the highest commercially available grade. 
Solubility measurement 
 The nucleobase solubilities were determined at 25 °C in the presence of 50 mM 
citrate–phosphate buffer as a function of pH or amino acid concentration. Excess amounts 
of the nucleobases were suspended in the buffer containing various concentrations of 
amino acids, NaCl or guanidine HCl and incubated at 40 °C for 1 h to accelerate 
dissolution. The suspension was brought to the solubility equilibrium at 25 ˚C for 24 h 
incubation. The suspension was centrifuged at 25 °C and 16,000g for 20 min to obtain 
saturated supernatants. Concentrations of the nucleobases in the supernatants were 
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determined by absorbance at 260 nm for adenine, 272 nm for guanine, 264 nm for 
thymine, 266 nm for cytosine, and 259 nm for uracil using a UV-vis spectrophotometer 
(ND-1000; NanoDrop Technologies, Inc., Wilmington, DE, USA). The solubilities were 
then calculated from the standard curves determined for each nucleobase. 
Calculation of transfer free energy 
 Transfer free energy ∆Gtr of the nucleobases from the buffer solution to the amino acid 
solutions was calculated according to the following equations. 
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In the equations shown above, μi signifies the chemical potential of nucleobase in the 
presence of i, and subscript w and a respectively denote the buffer solution and various 
concentrations of the amino acid (here arginine, lysine, glutamic acid, aspartic acid or 
glycine). Therein, μ0 and x are the standard chemical potential and the mole fraction at 
saturation. nj,i is the molarity of component j, where subscript base, H2O and a depict the 
nucleobase, water, and the amino acid in the presence of i. In addition, R is the gas 
constant; T is the absolute temperature. For example, μw represents the chemical potential 
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of a nucleobase in a buffer solution and nbase,w is the molarity of a nucleobase in the same 
solution. The activity coefficient was considered to be close to unity because of the poor 
solubility. 
DNA digestion 
The deoxyribonuclease (DNase) activity was assayed by measuring the liberation of 
acid-soluble oligonucleotides from deoxyribonucleic acid (DNA). The reaction mixture 
(60 µl) contained calf thymus DNA (final concentration of 0.4 mg/ml), 160 mM acetate 
buffer (pH 5.0), 4 mM ethylenediaminetetraacetic acid (EDTA) and DNase II. After 
incubation at 37 °C for an appropriate time, 25 µl of the mixture was mixed with a 12% 
perchloric acid for a final concentration of 2.5%. The mixture was chilled for 15 min and 
clarified by centrifugation at 4 °C for 10 min at 18,000g. A 20 µl of aliquot of the 
supernatant was diluted with 480 µl of distilled water and the absorbance at 260 nm was 
measured. Absorbance of the control solution was obtained from the sample solution 
without the enzyme. The absorbance value of the control was subtracted from that 
obtained from the respective sample solution. The enzymatic activity was defined as the 
final calculated absorbance. 
 
Results 
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The solubilities of nucleobases at neutral pH 
Nucleobases have poor aqueous solubilities. Table 1 presents solubilities of adenine, 
guanine, cytosine, thymine and uracil in citrate–phosphate buffer solution (50 mM, pH 7). 
All the nucleobases showed low solubilities of less than 100 mM. Among them, guanine 
was marginally soluble in the buffer solution. The solubility of the nucleobases 
determined here was compared with the literature values previously reported [19,20] 
(Table 1). Except for the guanine solubility, the present results were almost identical to 
the literature values. The observed solubility of guanine was about 3-fold higher than the 
literature value. In the present study, the nucleobases were first solubilized at 40 °C and 
brought to equilibrium at 25 °C; hence it is possible that guanine precipitation may still be 
occurring at the time of solubility measurement. However, it was confirmed that a 
prolonged incubation had no effect on the solubility of all five nucleobases, including 
guanine. Why is the guanine solubility 3-fold higher than the literature value? A careful 
examination showed that the solubility of guanine depended on the amount of powder in 
the initial solubilization. When a large excess of guanine was used, this higher value was 
observed. When a slight excess was used, a value close to the literature was obtained. 
Thus, guanine may form soluble oligomers in the higher solubility state, although no 
evidence for oligomer formation exists. The relative solubility of the nucleobases against 
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adenine was calculated as shown in Fig. 1. Cytosine exhibited 8-fold higher solubility 
than adenine. Thymine and uracil exhibited about 3-fold higher solubility than adenine.  
Solubilization effect of arginine on nucleobases 
The solubility of nucleobases at pH 7.0 in the presence of arginine was measured as a 
function of arginine concentration (Fig. 2). Arginine increased the solubility of all the 
nucleobases concentration-dependently. The solubility in guanidine at pH 7.0 is also 
presented in Fig. 2. To our surprise, the solubilizing effects of guanidine on adenine were 
substantially weaker than that of arginine; although, for other nucleobases, the effect of 
guanidine and arginine were similar. It is therefore evident that arginine is stronger than 
or at least equivalent to guanidine in enhancing the solubility of nucleobases. These 
results point out not only the importance of the guanidinium group, shared by these two 
additives, in increasing the solubility of the nucleobases, but also the contribution of other 
parts that cause a difference between arginine and guanidine in modulating between the 
solubility of the nucleobases. Figure 2 also presents solubility data in glycine and NaCl 
solutions at pH 7.0. Addition of the additives above was either ineffective (i.e., for 
guanine, cytosine and uracil) or unfavorable (i.e., adenine and thymine), consistent with 
the weak salting-out property of these additives [21]. 
The solubilizing effects of 1 M arginine solution at pH 7.0 were compared for 
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different nucleobases. Figure 3 shows that 1 M arginine greatly increased the solubility of 
adenine: by about 2.5-fold. The effects of 1 M arginine on the guanine and cytosine 
solubility were moderate––about 2-fold, whereas those on thymine and uracil were 
smaller. The magnitude of the solubility enhancement of arginine was unrelated to the 
solubility of nucleobases in buffer solution, as represented by the result that cytosine and 
guanine were similarly affected by arginine despite their different solubilities in buffer 
solution (Figs. 1 and 3). 
pH dependence of nucleobase solubilities in the presence of arginine 
The measurements described above were done at pH 7.0, at which these nucleobases 
are electrically neutral. Adenine, guanine, and cytosine have respective pKa values of 4.2, 
3.3 and 4.6. They are positively charged in acidic solution. Figure 4 shows the pH 
dependence of the solubility of these nucleobases in citrate–phosphate buffer solution. 
Because the solubility measurement of these nucleobases could not be done exactly at the 
target pH because of pH changes after dissolution of the nucleobases, the pH shown in 
Fig. 4 is the final pH of the supernatant after dissolution. As expected, the solubility of 
electrically neutral thymine and uracil showed no pH dependence whether 1 M arginine 
was absent or present. The solubility of these two nucleobases was consistently higher in 
the presence of 1 M arginine. Arginine changes the net charge at the carboxyl pKa, i.e., a 
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monovalent cation above ca. pH 2 and a divalent below this pH. The observed lack of pH 
dependence of thymine and uracil solubilities in 1 M arginine suggests that monovalent 
and divalent arginine have identical solubilizing effects on these nucleobases. 
On the other hand, the solubilities of adenine, guanine, and cytosine exhibited a 
distinct pH dependence: i.e., the solubility of these nucleobases increased concomitantly 
with decreasing pH. Such increased solubility at lower pH is consistent with the increased 
electrostatic potential by the protonation of nucleobases, which is expected to make the 
nucleobases in solution phase more energetically stable. The solubility of adenine showed 
a peculiar pH dependence, with a sudden decrease at pH 3.3 followed by a gradual 
increase below pH 3.1. That solubility might be attributable to a phase transition of the 
precipitate: i.e., the chemical potential of the precipitate became lower at pH 3.3 for 
unknown reasons, leading to decreased solubility. Unexpectedly, the solubility of these 
nucleobases was lower in 1 M arginine than in buffer when compared at an identical pH 
in the acidic region, indicating that 1 M arginine actually destabilizes the protonated form 
of the nucleobases. The ratio of the solubility in 1 M arginine to that in buffer is shown for 
guanine and cytosine in Fig. 5. Because no data exist at identical pH values in the 
presence and absence of arginine for each nucleobase, as shown in Fig. 4, the solubility 
ratio was calculated by interpolation of the data points. The solubilizing effect of 1 M 
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arginine steeply decreased as the pH is lowered below ca. pH 4 for guanine and ca. pH 5 
for cytosine. The solubilizing effect of 1 M arginine on guanine was lost at ca. pH 2.3, 
below which arginine decreased the solubility (i.e. solubility ratio less than 1). It is 
noteworthy that the midpoint of the ratio (ca. pH 3) was close to the pKa of guanine (pKa = 
3.3). A similar trend was apparent for cytosine (pKa = 4.6): the solubilizing effect was lost 
at pH 3.7 and the midpoint of the ratio was around pH 4. The observed different midpoint 
between these nucleobases and the fact that both monovalent and divalent forms of 
arginine had identical solubilizing effects on thymine and uracil suggest that the observed 
loss of solubilizing effects of arginine on guanine and cytosine at acidic regions are not 
caused by protonation of arginine, but by protonation of the nucleobases. Although not 
shown in Fig. 5, the observed suppression of adenine solubility by 1 M arginine below pH 
4 is also expected to be responsible for the protonation (Fig. 4). The unfavorable 
interaction between arginine and protonated nucleobases might be attributed to their 
mutual electrostatic repulsion. 
Solubility in different amino acid solutions 
Solubilizing effects of 1 M arginine were compared with those of other amino acids at 
pH 7.0. Figure 6A shows the solubility in grams per 100 g solvent of nucleobases in 1 M 
amino acid solutions; the solubility unit differs from the molar expression used in Fig. 2. 
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Only arginine significantly increased the solubility for all five nucleobases. Glycine did 
not affect the solubility, irrespective of the nature of the nucleobases. Both aspartic acid 
and glutamic acid slightly decreased the solubility of these nucleobases. The effects of 
lysine were variable, resulting in no change for adenine, a slight increase for cytosine and 
guanine, and slight decreases for thymine and uracil. The effects of aspartic and glutamic 
acids are consistent with their preferential hydration on proteins [1,22]. 
Thermodynamic effects of amino acid solution can be compared better using transfer 
free energy, i.e., Gibbs free energy required to transfer the compound from buffer solution 
to the solution containing an additive. The weight-based solubility, such as that shown in 
Fig. 6A, was used to calculate the transfer free energy. Figure 6B presents the transfer free 
energy of the nucleobases from the buffer solution to 1 M amino acid solutions at pH 7.0. 
Here, comparison of transfer free energy of guanine in the absence and presence of the 
additives assumes that guanine retains the higher solubility state, as mentioned before, 
even in the presence of the additives. It is evident that arginine greatly decreased the 
transfer free energy of all nucleobases, indicating that arginine favorably interacts with 
these nucleobases. However, a possibility cannot be excluded that the addition of arginine 
altered the interaction of buffer components (50 mM citrate–phosphate) with the 
nucleobases, resulting in increased solubility. This possibility may be less likely, since 
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other amino acids showed no increased solubility. The stabilizing effect of arginine was in 
the order of adenine > guanine ≈ cytosine > thymine ≈ uracil. This order is related to the 
number of double bonds in the six-membered ring: i.e., a greater number of double bonds 
in the ring imply a more favorable interaction between arginine and the nucleobase. 
Glycine was neutral to these nucleobases because the transfer free energy was more or 
less zero. The transfer free energy was slightly positive for aspartic and glutamic acid, in 
particular against adenine and thymine. Lysine showed small favorable interactions only 
with guanine and cytosine. 
DNA degradation 
The effects of arginine on DNA digestion by DNase II were examined at 37 °C in 0.16 
M acetate buffer (pH 5.0) as a preliminary experiment. A trend that the addition of 0.2 M 
arginine, but not NaCl, significantly inhibited DNA degradation was observed. Although 
this may be due to inhibitory effect of arginine on DNase II enzyme activity, another 
possibility could be the favorable interaction between arginine and nucleobases, which 
reduces affinity of the enzyme for the bases on DNA molecules.  
 
Discussion 
This paper described that arginine interacts favorably with nucleobases. Among the 
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amino acids tested, only arginine exhibited significant solubilizing and stabilizing effects 
on the nucleobases (Fig. 6), indicating that the guanidinium group of arginine is mainly 
responsible for the effect. Figure 6B shows that the transfer free energy of nucleobases 
decreases in 1 M arginine solution, i.e., the nucleobases are more stable in the arginine 
solution. The observed effects of arginine on nucleobases indicate that arginine increases 
the solubility not only of aromatic hydrocarbon-containing compounds but also of 
heteroaromatic compounds. The observed stronger effects on nucleobases with more 
double bonds imply that the favorable interaction of arginine with aromatic compounds 
arises from delocalized electron density. Although the physical mechanism of this 
interaction between arginine and electron cloud is not clear, the importance of such 
interaction in the observed arginine-enhanced solubility of nucleobases is evident from 
the pH dependence of the solubility (Fig. 4). Arginine decreased the solubility of adenine, 
guanine, and cytosine at acidic pH where they were protonated. Electrostatic repulsion 
between the positively charged arginine and the nucleobases should be responsible for the 
reduction of the favorable interaction as observed at neutral pH. It is likely that arginine is 
excluded from the nucleobases by the unfavorable electrostatic interaction and that such 
exclusion effects engender the salting-out effect of arginine on the nucleobases. Similar 
pH dependence has been observed with a salting-in salt, MgCl2 [23]. This salt showed 
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favorable interaction with proteins at neutral pH, accompanied by salting-in of the 
proteins. The same proteins showed decreased solubility in the presence of MgCl2 at low 
pH, where the proteins acquire positive charges. Concomitantly, MgCl2 showed 
exclusion from the proteins at acidic pH. 
Arginine has been used primarily in protein applications. The effects of arginine on 
proteins have been explained at least in part from its effects on aromatic hydrocarbon 
moiety, i.e., tryptophan, tyrosine and phenylalanine [6,24,25]. Other aromatic 
hydrocarbons, often found in drug substances, also show favorable interaction with 
arginine based on the interaction mechanism described above [17,18]. In this report, we 
described that arginine also increases the solubility of heteroaromatics, which also 
constitute many drug substances. Consequently, arginine might have wider applications 
as a solubility-enhancing additive. 
The observed solubilizing effects of nucleobases suggest that arginine might affect 
the solubility or stability of nucleic acids composed of four nucleobases. In general, short 
nucleic acids undergo reversible cooperative thermal melting, leading to exposure of 
nucleobases to the solvent (Fig. 7). Favorable interaction of arginine with the nucleobases 
should stabilize the melted state, i.e. a single strand with the nucleobases more 
solvent-exposed. However, arginine, being cationic, should more favorably interact with 
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the backbone of the nucleic acids, which has the higher negative charge density. The 
overall effect of arginine on the reversible melting of oligonucleotides will therefore be 
determined as a fine balance between electrostatic (stabilizing single and double strand) 
and aromatic (stabilizing single strand) interactions with arginine. We previously 
observed that arginine enhances the stability of DNA at less than 0.2 M and destabilizes 
the DNA at higher concentrations [26]. The stabilization effect is attributable to the 
contribution of electrostatic interaction between arginine and double-strand DNA. The 
destabilization at higher concentration is caused by the increasing contribution of the 
favorable interaction between nucleobases and arginine. Polymerase chain reaction 
(PCR) technology involves the melting of nucleic acids and therefore exposure of the 
nucleobases to solvents. The observed favorable interaction of arginine with the 
nucleobases implies that arginine may have a marked influence on PCR processes. 
We showed, although preliminary, that arginine inhibits DNA digestion by DNase II. 
The inhibition might be caused by decreased affinity of the enzyme for the nucleobases of 
the target DNA in the presence of arginine. The nucleobases had a lower free energy in 
the presence of arginine. Therefore, assuming that the nucleobases in the DNA, but not in 
the enzyme–DNA complex, interact with arginine, the binding constant of the enzyme to 
DNA is decreased by arginine. Perhaps for this reason, arginine caused slower kinetics of 
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DNA digestion. 
We reported previously that arginine effectively elutes adenosine triphosphate 
(ATP)-dependent enzymes from ATP-affinity columns: the bound enzymes are normally 
eluted by free ATP [27]. This observation is explainable at least in part in terms of the 
favorable interactions between nucleobases and arginine. Crystal structures of 
nucleotide–enzyme complexes, e.g. nucleoside diphosphate kinase–adenosine 
diphosphate (ADP) complexes, showed that adenine moiety is involved extensively in the 
ADP binding to the enzyme [28]. Assuming that ATP is solvent-exposed in the column, 
but not in the ATP–enzyme complex, the observed elution of the enzyme can be 
accounted for in part by the decreased free energy of nucleobases in the presence of 
arginine. 
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Fig 1. Ratios of nucleobase solubility to adenine solubility in buffer solution. 
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Fig 2. Solubilities of nucleobases in the presence of additives: (A) adenine; (B) guanine; 
(C) cytosine; (D) thymine; (E) uracil. Closed circles, arginine; open circles, guanidine; 
closed squares, glycine; open squares, NaCl. 
 20 
 
Fig 3. Ratios of nucleobase solubility in 1 M arginine solution to that in buffer solution. 
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Fig 4. pH Dependence of the nucleobase solubilities in the presence (closed symbols) and 
absence (open symbols) of 1 M arginine: (A) circles, thymine; squares, uracil; (B) 
adenine; (C) guanine; (D) cytosine. 
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Fig 5. Solubility ratios of nucleobases in the presence of 1 M arginine to that in the buffer 
solution at identical pH. Black line, guanine; gray line, cytosine. Data are taken from Fig. 
4 and calculated from interpolated values. 
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Fig 6. (A) Solubilities of nucleobases in 1 M amino acid solutions. (B) Transfer free 
energy of nucleobases from buffer solution to 1 M amino acid solutions. 
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Fig 7. Free energy diagram of single-strand and double-strand DNA in the presence 
(dotted line) and absence (solid line) of arginine. Hexagons and R respectively depict 
nucleobases composing DNA backbone and arginine. 
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Table 1 Solubilities of nucleobases at pH 7. 
 
Nucleobase Solubility × 103 (M) Solubilityref × 103 (M) a 
Adenine 8.20 ± 0.07 8.7 ± 0.1 
Guanine 0.111 ± 0.004 0.039 ± 0.001 
Cytosine 66.1 ± 0.5 65.8 ± 0.5 
Thymine 29.4 ± 0.2 27.8 ± 0.6 
Uracil 25.3 ± 0.4 23.8 ± 0.2 
a Data from Ref. [19] for adenine and guanine and Ref. [20] for 
cytosine, thymine and uracil. 
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